Examining the link between gut microbiota and AD

New findings suggest that gut microbiota (GMB) functional dynamics could be a potential biomarker of Alzheimer’s disease (AD) and neurodegeneration.

Specialists from centers in Milan, Italy, and Geneva, Switzerland, analyzed stool and blood samples collected from 72 older people with different levels of cognitive performance, including dementia.

They used a variety of methods, including sequencing and flow cytometry immunoassays, to determine the bacterial composition of the fecal samples and measure blood levels of lipopolysaccharide (LPS), short chain fatty acids (SCFAs), acetate, propionate, valerate, butyrate, and circulating adhesion molecules.

Vuoi saperne di più?

Accedi o registrati per accedere a tutti i contenuti di Neurodiem.

Hai già un account? Accedi

Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.